"10.1371_journal.pone.0117182","plos one","2015-02-06T00:00:00Z","Piia Lavikainen; Maarit Jaana Korhonen; Risto Huupponen; Arja Helin-Salmivaara","Department of Pharmacology, Drug Development and Therapeutics, University of Turku, Turku, Finland; Drug Research Doctoral Programme, University of Turku, Turku, Finland; Department of Public Health, University of Turku, Turku, Finland; Department of Clinical Pharmacology, Tykslab, Turku University Hospital, Turku, Finland; Unit of Primary Health Care, Hospital District of Helsinki and Uusimaa, Helsinki, Finland","Performed the experiments: AHS PL MJK RH. Analyzed the data: PL MJK. Wrote the paper: AHS PL MJK RH.","AHS, MJK and RH have been funded by the grants from the Social Insurance Institution and the Academy of Finland.  RH is a member of the Advisory Board for Social and Medical Affairs of the SII.  He has conducted consultancy for Orion Corporation as an Independent External Member of a Data Monitoring and Safety Committee in a clinical trial, and assisted Santen Pharmaceutical Co. in pharmacokinetic calculations.  PL has no conflict of interest.  The authors declare no other financial or non-financial (professional or personal) conflict of interests.  The authors declare that their competing interests do not alter their adherence to PLOS ONE policies on sharing data and materials.","2015","02","Piia Lavikainen","PL",4,TRUE,NA,4,2,4,TRUE,TRUE,FALSE,0,NA,FALSE
